Navigation Links
Smoking During Pregnancy

Australian Institute of Health and Welfare (AIHW) has published a report, which notes that 17.3% of women who gave birth in 2003 smoked during pregnancy.// The report noted that one in five Australian women smoked during pregnancy.

The rates were found to be much higher in aboriginals and teenage mothers than woman who gave birth later in life. "Smoking during pregnancy was most prevalent in teenage mothers, 42 per cent, compared to 10.9 per cent of mothers aged 35 years and older," said Elizabeth Sullivan, from AIHW's National Perinatal Statistics Unit.

The study found that 40% of women in remote areas smoked during pregnancy compared to 14% of women living in cities. The rate of smoking among aboriginals was found to be highest at 52%.

Despite the risks associated with smoking during pregnancy like increased risk of preterm baby and increased risk of low birth weight, the study found that the rate of decline is slow and is only about one percentage point per year.
'"/>




Page: 1

Related medicine news :

1. New hope on the Horizon for People Wishing to Quit Smoking
2. Cancers of Colon & Rectum linked to Cigarette Smoking
3. Smoking a greater risk than HIV? Yes say health experts!!!!
4. Kick Smoking with Nicotine Drink
5. Smoking spreads Cancer
6. Prescription Drug - Helps People Stop Smoking
7. Quit Smoking
8. Smoking can depreciate intellegence
9. Smoking Delays Pregnancy
10. Smoking Linked To Low Infant Birth Weight
11. GlaxoSmithKline To Cultivate Non-Smoking Environment
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Smoking During Pregnancy

(Date:5/16/2008)...ALEM, Pa., May 16 /PRNewswire/ -- Law Offices of H...to move to be a lead plaintiff in the,securities c... who,purchased or otherwise acquired the common st...ness Medical" or the "Company") (Amex: IMA ) in t... November 14, 2007 (the,"Class Period"). The share...
(Date:5/16/2008)...ong Campaign to Emphasize the Importance of Oral a...swire/ -- National dental insurer United,Concordia...laboration,between Oral Health America and the Bri...tance of oral health to overall health. Beginning ...ed States for the first time,making it the larges...
(Date:5/16/2008)...ngton) Declaring that Primary care medicine is in...resident of the American College of Physicians (AC...employers and consumers to issue a call for compre...eral internists and other primary care physicians....imary care medicine in the U.S., Dr. Dale and othe...
(Date:5/16/2008)...ive Web Cast Scheduled for May 19 at 10:15 a.m. Ea...ll/ - Response Biomedical,Corporation (TSX: RBM, O...ief Executive Officer, is scheduled to present at ...Conference on Monday May 19th at 10:15 a.m.,EDT., ...able on the Company,s,Web site at, http://www.resp...
Breaking Medicine News(10 mins):Health News:Law Offices of Howard G. Smith Announces 24 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Inverness Medical Innovations, Inc. 2Health News:United Concordia Dental Celebrates National Smile Month 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Response Biomedical Corporation to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference 2
...the male impotence drug Viagra may be useful for t...d for the treatment of high blood pressure and ang...ces levels of a naturally-occurring compound, cycl...e (cGMP). In the brain, cGMP has a vital function...
...the University of Michigan Health System, lotions ...that has become wrinkled through the normal aging...by exposure to the sun. Researchers tested lotion... is found in many skin-care products on the skin ...
...to look at the prevalence of XDR-TB, found this ty...ases, compared with about 4% in the United States...rains of tuberculosis that are resistant to at lea...iazid and rifampicin. XDR-TB is MDR-TB that is als...
...rategy of enhancing communication with family memb...an greatly reduce post-traumatic stress disorder,..., according to a study to be presented at the Amer... Conference in San Francisco on Monday, May 21. T...
Other Medicine News:Health News:Retinol Lotions Enhances Skin, Reduces Overall Aging 2Health News:XDR-TB a Serious Threat to India 2Health News:Improved Communication may Help to Accept the Death of Loved Ones With Poise 2
(Date:5/16/2008)...DGEWATER, N.J., May 16 /- Data from t... mean baseline hemoglobin (Hb) levels,and the rate...fect of,restrictions on reimbursement for erythrop...nts on the nation,s blood supply, will be presente...CO) Annual Meeting later this,month. The meeting w...
(Date:5/16/2008)...,s Technology Enables First-Ever PEGylation of a S...Therapeutic Activity, SAN CARLOS, Calif., May 16 ...daq: NKTR ) announced initial results today from .... The data shows significant,anti-tumor activity i...,also demonstrates that Nektar,s small molecule PE...
(Date:5/16/2008)...le Molecule with Dual Mechanism May Offer Novel Ap...Management, NEW ORLEANS, May 16 /PRNewswire-First... in the discovery and development of novel small,m...0, its first-in-class,Dual Acting Receptor Antagon... pressure reductions in a Phase 2a study in patien...
(Date:5/15/2008)...DCLIFF LAKE, N.J., May 15 /- Eisai Co...sults from 16 clinical data abstracts about,compou...rtfolio and,preclinical oncology research have bee...ting of the American Society of Clinical Oncology ...e 3, 2008., A wide variety of abstracts on Eisai ...
Breaking Medicine Technology:New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Angiotech to participate in Lehman Brothers Healthcare Conference 4021 1Nuvelo Announces Phase 2 SONOMA 3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 1542 1Nuvelo Announces Phase 2 SONOMA 3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 1542 2Nuvelo Announces Phase 2 SONOMA 3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 1542 3Nuvelo Announces Phase 2 SONOMA 3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 1542 4Clovis age overkill didnt take out Californias flightless sea duck 2530 1Clovis age overkill didnt take out Californias flightless sea duck 2530 2USP Announces Revised Glycerin Monograph 4019 1USP Announces Revised Glycerin Monograph 4019 2USP Announces Revised Glycerin Monograph 4019 3
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly.
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay.
MedLook 3.0 is a medical billing software.
...Billing Manager and Collections Administrator has ...alized billing models and personalized paper or el...e ability to facilitate rebilling, ledger notes, f... Onscreen Collections Worksheet and efficient coll...
Medicine Products: